Clinical trial
Infrared Coagulation in Preventing Anal Cancer in Patients With HIV Who Have…
NCT00066430 · AIDS Malignancy Consortium, Other · Completed
Key facts
| NCT number | NCT00066430 |
|---|---|
| Title | Infrared Coagulation in Preventing Anal Cancer in Patients With HIV Who Have Anal Neoplasia |
| Official title | Infrared Coagulator For Treatment Of High Grade Squamous Intraepithelial Neoplasia (HSIL) in the Anal Canal In HIV Infected Individuals: A Pilot Study |
| Lead sponsor | AIDS Malignancy Consortium, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Anal Cancer, Precancerous Condition |
| Intervention type | Device, Procedure |
| Interventions | infrared photocoagulation therapy, Infrared Coagulator |
| Enrollment | 18 |
| Start date | Sep 1, 2003 |
| Primary completion | Sep 1, 2004 |
| Completion | Apr 1, 2006 |
| First posted | Aug 7, 2003 |
| Last update posted | Sep 17, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: